{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:40:48Z","timestamp":1777480848731,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["theclinics.com","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.iac.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T03:53:30Z","timestamp":1427946810000},"page":"335-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Anaphylaxis to Chemotherapy and Monoclonal Antibodies"],"prefix":"10.1016","volume":"35","author":[{"given":"Mariana C.","family":"Castells","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2015.01.011_bib1","first-page":"458","article-title":"Hypersensitivity reactions","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7150\/ijms.8.332","article-title":"Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS","volume":"8","author":"Sakaeda","year":"2011","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.iac.2015.01.011_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1756-9966-30-93","article-title":"Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS","volume":"30","author":"Kadoyama","year":"2011","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.iac.2015.01.011_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.iac.2015.01.011_bib5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaci.2011.10.010","article-title":"A\u00a0protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions","volume":"129","author":"Patil","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib9","first-page":"170","article-title":"Immunoglobulin E-mediated severe anaphylaxis to paclitaxel","volume":"20","author":"Prieto Garcia","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2015.01.011_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000335637","article-title":"Desensitization for hypersensitivity reactions to medications","volume":"97","author":"del Carmen Sancho","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.iac.2015.01.011_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","author":"McNeil","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.iac.2015.01.011_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11882-014-0453-5","article-title":"Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes","volume":"14","author":"Hsu Blatman","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2015.01.011_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","article-title":"Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization","volume":"2","author":"Wong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2015.01.011_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40259-013-0066-x","article-title":"Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy","volume":"28","author":"Mezzano","year":"2014","journal-title":"BioDrugs"},{"key":"10.1016\/j.iac.2015.01.011_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/bjc.2013.389","article-title":"Deleterious BRCA1\/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions","volume":"109","author":"Moon","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.iac.2015.01.011_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1398-9995.2004.00521.x","article-title":"Occupational hypersensitivity to metal salts, including platinum, in the secondary industry","volume":"60","author":"Cristaudo","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2015.01.011_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1015853200090","article-title":"Hypersensitivity reactions to carboplatin in children","volume":"58","author":"Lazzareschi","year":"2002","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.iac.2015.01.011_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ACI.0b013e3280108716","article-title":"Desensitization for drug allergy","volume":"6","author":"Castells","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaip.2014.04.010","article-title":"Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review","volume":"2","author":"Banerji","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2015.01.011_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ygyno.2004.11.043","article-title":"Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments","volume":"96","author":"Feldweg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib24","first-page":"317","article-title":"Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin","volume":"16","author":"Decorti","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.iac.2015.01.011_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2500\/aap.2011.32.3409","article-title":"A\u00a0fatal anaphylactic reaction to paclitaxel is described, which was preceded by a\u00a0possible delayed reaction to the initial infusion","volume":"32","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2015.01.011_bib26","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1200\/JCO.2002.20.11.2760","article-title":"Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel","volume":"20","author":"Denman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/IGC.0b013e3181a38e2f","article-title":"Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel","volume":"19","author":"Fader","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.iac.2015.01.011_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00129804-200505000-00004","article-title":"Improving patient outcomes in an ambulatory infusion setting: decreasing infusion reactions of patients receiving paclitaxel and carboplatin","volume":"28","author":"Huddleston","year":"2005","journal-title":"J\u00a0Infus Nurs"},{"key":"10.1016\/j.iac.2015.01.011_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7326\/0003-4819-94-1-66","article-title":"Hypersensitivity reactions to cancer chemotherapeutic agents","volume":"94","author":"Weiss","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2015.01.011_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0091-6749(98)70262-3","article-title":"Hypersensitivity reactions to Escherichia coli-derived polyethylene glycolated-asparaginase associated with subsequent immediate skin test reactivity to E. coli-derived granulocyte colony-stimulating factor","volume":"101","author":"Stone","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaci.2008.10.034","article-title":"Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia","volume":"123","author":"Soyer","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib32","first-page":"309","article-title":"Desensitization therapy of acute lymphocytic leukemia with injection of L-asparaginase (Report of 5 cases)","volume":"43","author":"Guo","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.iac.2015.01.011_bib33","first-page":"959","article-title":"Hypersensitivity reactions induced by etoposide","volume":"68","author":"O'Dwyer","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.iac.2015.01.011_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/eci.11.75","article-title":"Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies","volume":"8","author":"Hong","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.iac.2014.04.008","article-title":"Hypersensitivity reactions to biologic agents","volume":"34","author":"Vultaggio","year":"2014","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.iac.2015.01.011_bib36","first-page":"250","article-title":"Monoclonal antibodies, immunogenicity, and associated infusion reactions","volume":"72","author":"Cheifetz","year":"2005","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.iac.2015.01.011_bib37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity - a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2015.01.011_bib38","first-page":"451","article-title":"Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer-Identification, prevention, and management","volume":"5","author":"Kang","year":"2007","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1398-9995.2009.02280.x","article-title":"Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions","volume":"65","author":"Vultaggio","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2015.01.011_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.aller.2012.04.006","article-title":"Injection site reaction to adalimumab: positive skin test and successful rapid desensitisation","volume":"41","author":"Bavbek","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2015.01.011_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000051713","article-title":"Rituximab-induced vasculitis","volume":"203","author":"Dereure","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.iac.2015.01.011_bib42","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/1529-0131(200107)44:7<1717::AID-ART299>3.0.CO;2-C","article-title":"Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab)","volume":"44","author":"D'Arcy","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.iac.2015.01.011_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jemermed.2005.01.033","article-title":"Serum sickness-like reactions in patients receiving intravenous infliximab","volume":"30","author":"Gamarra","year":"2006","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.iac.2015.01.011_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2007.06.038","article-title":"Severe serum sickness-like syndrome after omalizumab therapy for asthma","volume":"120","author":"Pilette","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00042737-200406000-00018","article-title":"Severe anaphylactic reaction to infliximab: successful treatment with adalimumab - report of a case","volume":"16","author":"Stallmach","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.iac.2015.01.011_bib46","series-title":"Drug hypersensitivity","first-page":"413","article-title":"Drug desensitization in oncology: chemotherapy agents and monoclonal antibodies","author":"Castells","year":"2007"},{"key":"10.1016\/j.iac.2015.01.011_bib47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2015.01.011_bib48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.21671","article-title":"Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis","volume":"54","author":"Wolbink","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.iac.2015.01.011_bib49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","article-title":"Anaphylaxis: lessons from mouse models","volume":"120","author":"Finkelman","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2015.01.011_bib50","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s11739-011-0611-x","article-title":"Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction","volume":"7","author":"Vultaggio","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.iac.2015.01.011_bib51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.MIB.0000158166.88238.ea","article-title":"Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium","volume":"11","author":"Jacobstein","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.iac.2015.01.011_bib52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaci.2009.08.026","article-title":"Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant","volume":"124","author":"Commins","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib53","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","article-title":"Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity","volume":"21","author":"Markman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.iac.2015.01.011_bib54","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2007.04.044","article-title":"Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer","volume":"197","author":"Callahan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.iac.2015.01.011_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaip.2013.06.002","article-title":"Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy","volume":"1","author":"Caiado","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2015.01.011_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/all.12105","article-title":"Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment","volume":"68","author":"Madrigal-Burgaleta","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2015.01.011_bib57","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1248\/bpb.b12-00150","article-title":"Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer","volume":"35","author":"Iwamoto","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.iac.2015.01.011_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)61136-2","article-title":"Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen","volume":"94","author":"Morales","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10875-011-9605-8","article-title":"In\u00a0vitro desensitization of human skin mast cells","volume":"32","author":"Zhao","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.iac.2015.01.011_bib60","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaci.2013.05.004","article-title":"Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells","volume":"132","author":"Oka","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T19:28:28Z","timestamp":1566502108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856115000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0889856115000120"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2015.01.011","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis to Chemotherapy and Monoclonal Antibodies","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}